Department of Laboratory Medicine, WuHan PuRen Hospital, Wuhan, Hubei, China (mainland).
Med Sci Monit. 2021 Feb 27;27:e928919. doi: 10.12659/MSM.928919.
BACKGROUND Breast cancer, a common malignant tumor, has been considered as the leading cause of cancer-related death in women. Collagen type X alpha 1 (COL10A1) is overexpressed in breast cancer. The current study was designed to determine the functional involvement and regulatory mechanism of COL10A1 on the growth and metastasis of breast cancer. MATERIAL AND METHODS COL10A1 and Prolyl 4-hydroxylase beta polypeptide (P4HB) expressions in normal tissues and tumor tissues of breast cancer patients were obtained from the GEPIA dataset. COL10A1 and P4HB levels in breast cancer cell lines were detected by real-time quantitative polymerase chain reaction (RT-qPCR) and western blot analysis. Furthermore, the interaction between COL10A1 and P4HB was confirmed by co-immunoprecipitation (Co-IP) assay. Cell Counting Kit-8 (CCK-8) and colony formation assay were applied to evaluate cell proliferation and clone-forming abilities of breast cancer cells. In addition, wound healing assay and transwell assay were performed to measure cell migration and invasion capabilities, respectively, in breast cancer. RESULTS The GEPIA dataset presented overexpressed COL10A1 and P4HB in tumor tissues of breast cancer patients. COL10A1 and P4HB expression levels were greatly upregulated in breast cancer cell lines. In addition, COL10A1 could directly interact with P4HB. Functionally, overexpressed COL10A1 boosted the proliferation and metastasis of breast cancer cells and silenced COL10A1 impeded the progression of breast cancer. More importantly, knockdown of P4HB weakened the promoting effects of overexpressed COL10A1 on cell proliferation, migration, and invasion in breast cancer. CONCLUSIONS COL10A1 promotes the malignant progression of breast cancer by upregulating P4HB expression, indicating that COL10A1 functions as an oncogene in breast cancer.
乳腺癌是一种常见的恶性肿瘤,已被认为是女性癌症相关死亡的主要原因。胶原 X 型α 1(COL10A1)在乳腺癌中过表达。本研究旨在确定 COL10A1 对乳腺癌生长和转移的功能参与和调节机制。
从 GEPIA 数据集获得乳腺癌患者正常组织和肿瘤组织中的 COL10A1 和脯氨酰 4-羟化酶 β 多肽(P4HB)表达。通过实时定量聚合酶链反应(RT-qPCR)和 Western blot 分析检测乳腺癌细胞系中 COL10A1 和 P4HB 的水平。此外,通过共免疫沉淀(Co-IP)试验证实 COL10A1 和 P4HB 之间的相互作用。细胞计数试剂盒-8(CCK-8)和集落形成试验分别用于评估乳腺癌细胞的增殖和克隆形成能力。此外,进行划痕愈合试验和 Transwell 试验分别测量乳腺癌细胞的迁移和侵袭能力。
GEPIA 数据集显示乳腺癌患者肿瘤组织中 COL10A1 和 P4HB 过表达。COL10A1 和 P4HB 的表达水平在乳腺癌细胞系中显著上调。此外,COL10A1 可以直接与 P4HB 相互作用。功能上,过表达 COL10A1 促进乳腺癌细胞的增殖和转移,而沉默 COL10A1 则阻碍乳腺癌的进展。更重要的是,沉默 P4HB 减弱了过表达 COL10A1 对乳腺癌细胞增殖、迁移和侵袭的促进作用。
COL10A1 通过上调 P4HB 表达促进乳腺癌的恶性进展,表明 COL10A1 在乳腺癌中作为癌基因发挥作用。